CORFLOW THERAPEUTICS AG – Trademark Portfolio

Entity Type: 25

CORFLOW THERAPEUTICS AG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CORFLOW.

Neuhofstrasse 3d

CH-6340 Baar

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CORFLOW
CORFLOW
Registered 2023
CORFLOW
CORFLOW
Registered 2023

Trademark Classifications

CORFLOW THERAPEUTICS AG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CORFLOW THERAPEUTICS AG have?

CORFLOW THERAPEUTICS AG has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does CORFLOW THERAPEUTICS AG file in?

CORFLOW THERAPEUTICS AG files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are CORFLOW THERAPEUTICS AG's most well-known trademarks?

CORFLOW THERAPEUTICS AG's registered trademark portfolio includes well-known marks such as CORFLOW. These are among 2 currently registered trademarks in the portfolio.

What is CORFLOW THERAPEUTICS AG's trademark registration success rate?

CORFLOW THERAPEUTICS AG has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.